| Dysfunctional high-density lipoprotein in patients on chronic hemodialysis S Yamamoto, PG Yancey, TA Ikizler, WG Jerome, R Kaseda, B Cox, ... Journal of the American College of Cardiology 60 (23), 2372-2379, 2012 | 219 | 2012 |
| Low Concentrations of Sodium Dodecyl Sulfate Induce the Extension of β2-Microglobulin-Related Amyloid Fibrils at a Neutral pH S Yamamoto, K Hasegawa, I Yamaguchi, S Tsutsumi, J Kardos, Y Goto, ... Biochemistry 43 (34), 11075-11082, 2004 | 215 | 2004 |
| Glycosaminoglycans enhance the trifluoroethanol-induced extension of β2-microglobulin–related amyloid fibrils at a neutral pH S Yamamoto, I Yamaguchi, K Hasegawa, S Tsutsumi, Y Goto, F Gejyo, ... Journal of the American Society of Nephrology 15 (1), 126-133, 2004 | 175 | 2004 |
| Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients JJ Kazama, F Sato, K Omori, H Hama, S Yamamoto, H Maruyama, I Narita, ... Kidney international 67 (3), 1120-1125, 2005 | 167 | 2005 |
| Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis S Yamamoto, PG Yancey, Y Zuo, LJ Ma, R Kaseda, AB Fogo, I Ichikawa, ... Arteriosclerosis, thrombosis, and vascular biology 31 (12), 2856-2864, 2011 | 129 | 2011 |
| Mechanisms for increased cardiovascular disease in chronic kidney dysfunction S Yamamoto, V Kon Current opinion in nephrology and hypertension 18 (3), 181-188, 2009 | 129 | 2009 |
| Historical background and clinical treatment of dialysis-related amyloidosis S Yamamoto, F Gejyo Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1753 (1), 4-10, 2005 | 114 | 2005 |
| Glycosaminoglycan and proteoglycan inhibit the depolymerization of β2-microglobulin amyloid fibrils in vitro I Yamaguchi, H Suda, N Tsuzuike, K Seto, M Seki, Y Yamaguchi, ... Kidney international 64 (3), 1080-1088, 2003 | 107 | 2003 |
| Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice S Yamamoto, Y Zuo, J Ma, PG Yancey, TE Hunley, M Motojima, AB Fogo, ... Nephrology Dialysis Transplantation 26 (8), 2491-2497, 2011 | 87 | 2011 |
| Continuous reduction of protein-bound uraemic toxins with improved oxidative stress by using the oral charcoal adsorbent AST-120 in haemodialysis patients S Yamamoto, JJ Kazama, K Omori, K Matsuo, Y Takahashi, K Kawamura, ... Scientific reports 5 (1), 14381, 2015 | 85 | 2015 |
| High mortality rate of infectious diseases in dialysis patients: a comparison with the general population in Japan M Wakasugi, K Kawamura, S Yamamoto, JJ Kazama, I Narita Therapeutic Apheresis and Dialysis 16 (3), 226-231, 2012 | 83 | 2012 |
| A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study M Wakasugi, JJ Kazama, S Yamamoto, K Kawamura, I Narita Hypertension research 36 (4), 328-333, 2013 | 76 | 2013 |
| Cause‐specific excess mortality among dialysis patients: comparison with the general population in Japan M Wakasugi, JJ Kazama, S Yamamoto, K Kawamura, I Narita Therapeutic Apheresis and Dialysis 17 (3), 298-304, 2013 | 74 | 2013 |
| Recent progress in understanding dialysis-related amyloidosis S Yamamoto, JJ Kazama, I Narita, H Naiki, F Gejyo Bone 45, S39-S42, 2009 | 71 | 2009 |
| Removal of uremic toxins by renal replacement therapies: a review of current progress and future perspectives S Yamamoto, JJ Kazama, T Wakamatsu, Y Takahashi, Y Kaneko, S Goto, ... Renal Replacement Therapy 2, 1-8, 2016 | 65 | 2016 |
| Indoxyl sulfate promotes macrophage IL-1β production by activating aryl hydrocarbon receptor/NF-κ/MAPK cascades, but the NLRP3 inflammasome was not activated T Wakamatsu, S Yamamoto, T Ito, Y Sato, K Matsuo, Y Takahashi, ... Toxins 10 (3), 124, 2018 | 61 | 2018 |
| Uremic toxicity and bone in CKD S Yamamoto, M Fukagawa Journal of nephrology 30, 623-627, 2017 | 60 | 2017 |
| Use of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients S Yamamoto, R Kido, Y Onishi, S Fukuma, T Akizawa, M Fukagawa, ... PloS one 10 (4), e0122691, 2015 | 58 | 2015 |
| Administration of ferric citrate hydrate decreases circulating FGF23 levels independently of serum phosphate levels in hemodialysis patients with iron deficiency A Iguchi, JJ Kazama, S Yamamoto, K Yoshita, Y Watanabe, N Iino, I Narita Nephron 131 (3), 161-166, 2015 | 48 | 2015 |
| Increased proinflammatory cytokine production and decreased cholesterol efflux due to downregulation of ABCG1 in macrophages exposed to indoxyl sulfate K Matsuo, S Yamamoto, T Wakamatsu, Y Takahashi, K Kawamura, ... Toxins 7 (8), 3155-3166, 2015 | 48 | 2015 |
Ichiei Narita新潟大学、医学部、腎・膠原病内科学、教授在 med.niigata-u.ac.jp 的电子邮件经过验证
